Enjoy complimentary customisation on priority with our Enterprise License!
The Urticaria Drugs Market size is forecast to increase by USD 1.66 billion, at a CAGR of 11.64% between 2023 and 2028.
There has been an increasing approval of new drugs for urticaria across the world. In addition, urticaria has a strong pipeline, considering the early and late-stage pipeline candidates. Moreover, most drugs are anti-allergens that have a symptomatic management approach. In addition, few promising molecules in the pipeline have disease-modifying activities for chronic spontaneous urticaria, acute urticaria, angioedema, and others. Furthermore, major companies such as Novartis AG, Amneal Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., and Viatris Inc. have a strong pipeline in their portfolios for urticaria indication. Hence, such factors are positively impacting the market.
Technavio has segmented the market into Application, Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.